Table 3.
Laboratory findings.
| Items |
With fatigue |
Without fatigue |
|
|---|---|---|---|
| (n = 35) |
(n = 188) |
p-value |
|
| Blood test, median[IQR] | |||
| WBC count, ∗10ˆ9/L | 5.5 (3.7, 6.2) | 5.2 (3.9, 6.3) | 0.749 |
| Neutrophil/Lymphocyte, | 0.4 (0.3, 0.7) | 0.4 (0.3, 0.5) | 0.072 |
| CD3+, % | 780.0 (581.0, 1051.0) | 746.0 (589.3, 958.0) | 0.470 |
| CD3+CD4+, % | 472.0 (297.0, 705.0) | 448.0 (334.0, 548.0) | 0.479 |
| CD3+CD8+, % | 265.0 (165.0, 343.0) | 253.0 (170.0, 356.0) | 0.623 |
| CD16+CD56+, % | 194.0 (134.0, 248.0) | 242.0 (179.0, 373.0) | 0.075 |
| CD19+, % | 129.0 (93.0, 190.0) | 134.0 (85.0, 208.0) | 0.306 |
| Hemoglobin,g/L | 128.0(121.5136.5) | 131.0(120.8144.0) | 0.355 |
| Platelet,∗10ˆ9/L | 193.0 (154.5, 224.5) | 179.5 (145.8, 227.0) | 0.723 |
| C-reactive protein, mg/L | 3.7 (1.8, 7.7) | 3.7 (1.6, 9.0) | 0.723 |
| Creatine kinase, U/L | 79.0 (60.5, 112.0) | 85.5 (58.0, 129.8) | 0.556 |
| Lactate dehydrogenase, U/L | 200.0 (173.0, 229.0) | 208.0 (181.0, 236.5) | 0.699 |
| ALT, U/L | 17.0 (13.0, 36.0) | 17.0 (12.0, 26.0) | 0.688 |
| AST, U/L | 26.0 (21.5, 38.0) | 25.0 (19.5, 33.0) | 0.720 |
| TBil, mmol/L | 10.2 (8.3, 12.8) | 10.4 (7.8, 14.2) | 0.546 |
| Albumin, g/L | 39.0 (38.0, 43.5) | 40.0 (37.8, 43.0) | 0.903 |
| D-dimer, mg/L | 0.4 (0.2, 0.6) | 0.4 (0.2, 0.7) | 0.826 |
| Blood urea nitrogen, | 4.7 (4.1, 5.6) | 5.1 (4.2, 6.3) | 0.292 |
| Creatinine, umol/L | 70.0 (59.5, 83.5) | 76.0 (63.0, 88.5) | 0.144 |
| IL-6, pg/mL | 7.3 (4.8, 9.2) | 5.1 (3.5, 7.4) | 0.048∗ |
| IL-8, pg/mL | 11.7 (8.5, 22.1) | 12.7 (9.0, 18.0) | 0.570 |
| TNF-α, pg/mL | 9.4 (7.3, 11.5) | 8.7 (6.5, 11.5) | 0.891 |
| Lactic acid, mmol/L | 1.4 (0.9, 2.1) | 1.3 (1.0, 1.7) | 0.696 |
| ESR, mm/h | 17.5 (8.0, 26.8) | 18.0 (11.0, 28.0) | 0.744 |
| Myohemoglobin, μg/L | 26.9 (19.6, 40.9) | 30.3 (20.6, 49.9) | 0.873 |
| PT, s | 10.9 (10.5, 11.3) | 10.9 (10.5, 11.5) | 0.310 |
| APTT, s | 27.6 (26.1, 29.3) | 28.5 (26.7, 30.7) | 0.114 |
| Fibrinogen, g/L | 2.9 (2.5, 3.5) | 3.1 (2.7, 3.6) | 0.341 |
| Chest CT findings, n(%) | |||
| Bilateral lung involvement | 18 (51.4) | 75 (39.9) | 0.281 |
| Patchy shadowing | 1 (2.9) | 9 (4.8) | 0.700 |
| Ground-glass opacity | 3 (8.6) | 7 (3.7) | 0.216 |
| Interstitial abnormalities | 3 (8.6) | 14 (7.4) | 0.819 |
| Consolidation | 2 (5.7) | 2 (1.1) | 0.089 |